I’m not agreeing with Luly—just reporting what he said today. However, it’s worth noting that (NS5A-free) Sovaldi + Olysio is a semi-bootleg regimen that doesn’t have a lot of data on efficacy in hard-to-treat subgroups.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”